Form 4: Tango Therapeutics President Sells Shares

Sentiment:

Insider Transaction (Form 4)


Adam Crystal, President, R&D of Tango Therapeutics, Inc., sold 27,000 shares of common stock on October 1, 2026.

Summary

  • Option exercise/conversion: acquired 27,000 Common Stock at $5.20 ($140,400) on October 1, 2026; holds 142,743 after (Direct).
  • Open-market sale: disposed of 26,400 Common Stock at $24.45 ($645,604) on October 1, 2026; holds 116,343 after (Direct).
  • Open-market sale: disposed of 600 Common Stock at $25.32 ($15,192) on October 1, 2026; holds 115,743 after (Direct).
  • Option exercise/conversion: disposed of 27,000 Stock Option (Right to Buy) on October 1, 2026; holds 233,040 after (Direct).

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $660,796 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.

Insider Transactions

Adam Crystal — Officer (President, R&D)

Transaction made under a Rule 10b5-1 trading plan.

DateTransactionSecuritySharesPriceValueHeld After
2026-10-01Option exercise/conversionCommon Stock27,000$5$140.4K142,743
2026-10-01Open-market saleCommon Stock26,400$24$645.6K116,343
2026-10-01Open-market saleCommon Stock600$25$15.2K115,743
2026-10-01Option exercise/conversionStock Option (Right to Buy)27,000——233,040

Key Dates

DateDescription
2026-10-01Option exercise/conversion (27,000 shares)
2026-10-01Open-market sale (26,400 shares)
2026-10-01Open-market sale (600 shares)
2026-10-01Option exercise/conversion (27,000 shares)

Keywords

insider transaction, Form 4, TNGX, Tango Therapeutics, Inc., bearish, Adam Crystal

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.